Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal BPC 157 Peptide Hormone Replacement Therapy Los Angeles BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Here's a guide I created for those curious about the healing peptide BPC 157. Currently on my third cycle of this peptide (paired with TB 500 Thymosin Beta 4) and will share my experience with